MCI patients with both decreased parietal blood flow and pathological levels of cerebrospinal tau and CSF Aβ1-42 were at very high risk of subsequent progression to AD, as well as a further more accelerated neurodegenerative process.14 This evidence concerns the gene MAPT and Alzheimer disease.